Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Strategies for purging latently infected cells in HIV-positive patients studied at NIAID

Feb. 4, 1998

Promising efficacy reported at AIDS conference for amprenavir combinations

Feb. 3, 1998

Potent antiretroviral activity shown for abacavir + protease inhibitor in HIV-positive patients

Feb. 3, 1998

Swiss Remune trials initiated

Jan. 29, 1998

PMPA reduces viral load in phase I/II

Jan. 29, 1998

Triangle reports results from phase I/II FTC trial

Jan. 29, 1998

ACT evaluated in second phase I trial in HIV/AIDS patients

Jan. 28, 1998

New AIDS therapies in development in Korea

Jan. 28, 1998

Viracept approved for marketing in E.U. member countries

Jan. 23, 1998

Irreversible HIV protease inhibitors under evaluation at LG Chemical

Jan. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.